The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity
Open Access
- 1 July 1970
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 49 (7) , 1381-1388
- https://doi.org/10.1172/jci106355
Abstract
Polymorphonuclear neutrophils (PMN) from patients with chronic granulomatous disease of childhood have impaired bactericidal activity and are deficient in diphosphopyridine nucleotide, reduced form of, (NADH) oxidase. Since hydrocortisone had been shown to inhibit NADH oxidation, experiments were undertaken to determine the effect of hydrocortisone on several parameters of human PMN function. The phagocytic and bactericidal capacity of PMN with or without hydrocortisone (2.1 mM) was determined by quantitation of cell-free, cell-associated, and total bacteria. Phagocytosis of Staphylococcus aureus and several gram-negative rods was unimpaired by the presence of hydrocortisone in the media. In contrast, killing of bacteria was markedly impaired by hydrocortisone. After 30 min of incubation, there were 20-400 times as many bacteria surviving in hydrocortisone-treated PMN as in simultaneously run controls without hydrocortisone. The defect of intracellular killing noted in the presence of hydrocortisone was not related to impaired degranulation. Quantitative kinetic studies of degranulation revealed no difference in the release of granule associated acid phosphatase in hydrocortisone-treated and control PMN after phagocytosis. Electron microscopy of PMN also indicated that the presence of hydrocortisone had no effect on the extent of degranulation after phagocytosis. These observations were confirmed by studies using histochemical techniques to detect lysosomal enzymes. After phagocytosis, hydrocortisone-treated PMN demonstrated less NADH oxidase activity, oxygen consumption, and hydrogen peroxide production than postphagocytic control PMN. In addition, Nitro blue tetrazolium dye reduction was diminished in hydrocortisone-treated PMN. Thus, impairment of NADH oxidase activity in normal human PMN by hydrocortisone results in reduced intracellular killing of bacteria, diminished postphagocytic oxygen consumption, decreased ability to reduce Nitro blue tetrazolium, and decreased hydrogen peroxide production. These abnormalities are similar to those seen in the PMN of patients with chronic granulomatous disease of childhood.Keywords
This publication has 26 references indexed in Scilit:
- Degranulation of leukocytes in chronic granulomatous diseaseJournal of Clinical Investigation, 1969
- ARGININE-RICH PROTEINS OF POLYMORPHONUCLEAR LEUKOCYTE LYSOSOMESThe Journal of Experimental Medicine, 1968
- IODINATION OF BACTERIA: A BACTERICIDAL MECHANISMThe Journal of Experimental Medicine, 1967
- The Dissociation by Colchicine of Phagocytosis from Increased Oxygen Consumption in Human Leukocytes*Journal of Clinical Investigation, 1967
- A NEWLY DEFINED X-LINKED TRAIT IN MAN WITH DEMONSTRATION OF THE LYON EFFECT IN CARRIER FEMALESThe Lancet, 1967
- IMPROVEMENTS IN EPOXY RESIN EMBEDDING METHODSThe Journal of cell biology, 1961
- INHIBITION OF THE ENZYMIC OXIDATION OF DPNH BY STER HORMONESProceedings of the National Academy of Sciences, 1959
- Staining of Tissue Sections for Electron Microscopy with Heavy MetalsThe Journal of cell biology, 1958
- THE SURVIVAL OF STAPHYLOCOCCI WITHIN HUMAN LEUKOCYTESThe Journal of Experimental Medicine, 1952
- The Action of Vital Stains Belonging to the Benzidine GroupScience, 1914